COMMUNIQUÉS West-GlobeNewswire

Emblem Completes Supply Agreement with Alberta Gaming, Liquor & Cannabis Commission (AGLC)
05/07/2018
PARIS, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the "Company") is pleased to announce that its wholly owned subsidiary, Emblem Cannabis Corporation, one of Canada’s [...]
Ogilvy CommonHealth Worldwide continues to fuel the network’s creative department with promotions and new talent
05/07/2018
PARSIPPANY, N.J., July 05, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP) ( www.wpp.com ), announced three promotions and one new hire [...]
Clementia Appoints Industry Executive Shawn Tomasello to its Board of Directors
05/07/2018
Accomplished Biopharma Leader Brings Over 30 Years of Experience Leading Strategic and Commercial Efforts MONTREAL, July 05, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical-stage [...]
Clementia nomme Shawn Tomasello, une cadre chevronnée de l’industrie, au sein de son conseil d’administration
05/07/2018
Une leader accomplie de la biopharmaceutique qui apporte 30 ans d’expérience en direction d’initiatives stratégiques et commerciales MONTRÉAL, 05 juill. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (NASDAQ: [...]
Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes
05/07/2018
LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH) announces that patient screening and recruitment has begun in its regenerative medicine [...]
Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018
05/07/2018
ORION CORPORATION PRESS RELEASE 5 JULY 2018 at 11.30 EEST Publishing of Orion Corporation's Half-Year Financial Report for January-June 2018 on 18 July 2018 Orion will publish its Half-Year Financial Report for January- [...]
Merus Announces Annual Meeting of Shareholders
05/07/2018
UTRECHT, The Netherlands, July 05, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]
Solon Eiendom ASA : Major shareholding and primary insider notification
05/07/2018
(Oslo, Norway, July 4, 2018) UFI AS has today bought 251.087 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]
Biohit Oyj B-shares Subscribed with Stock Options I 2013
05/07/2018
Biohit Oyj Stock Exchange Release July 5, 2018 at 09:30 a.m. (EEST) A total number of 10,054 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 7 February 2018 and 4 June 2018. These [...]
Shire plc : Rule 2.9 Announcement
05/07/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 July 2018 Shire [...]
Santhera to Present Novel Data Highlighting the Clinical Relevance of Peak Expiratory Flow as Predictor of Disease Progression in Duchenne Muscular Dystrophy
05/07/2018
Pratteln, Switzerland, July 5, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that new data further supporting the clinical relevance of Peak Expiratory Flow (PEF) and providing a link between the treatment [...]
Sienna Announces Second Quarter 2018 Results Release Date and Conference Call
04/07/2018
MARKHAM, Ontario, July 04, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX:SIA) announced that it will report its 2018 second quarter results after market close on Wednesday, [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2018
04/07/2018
Disclosure of Share Capital and Voting Rights Outstanding as of June 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2018
04/07/2018
Nombre total de droits de vote et d'actions composant le capital social au 30 juin 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France ( [...]
VALNEVA : Declaration d'actions et de droits de vote de juin 2018
04/07/2018
VALNEVA Déclaration d'actions et de droits de vote - JUIN 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
VALNEVA : Bilan semestriel du contrat de liquidité
04/07/2018
Paris, le 4 juillet 2018 Bilan semestriel du contrat de liquidité VALNEVA contracté avec NATIXIS Au titre du contrat de liquidité confié à NATIXIS portant sur les actions de la société VALNEVA, à la date du 29 juin 2018 [...]
New software application provides Canadians easy access to healthcare through their smart device
04/07/2018
GOeVisit’s new technology is transforming how individuals receive medical care VANCOUVER, British Columbia, July 04, 2018 (GLOBE NEWSWIRE) -- GOeVisit SmartExam (SmartExam), a service pioneered by MyCare MedTech Inc., [...]
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA® (Tesamorelin for Injection) for FDA Approval
04/07/2018
MONTREAL, July 04, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that it has filed a supplemental new drug application (sNDA) with the Food and Drug Administration (FDA) [...]
Theratechnologies soumet à la FDA une nouvelle formulation d’EGRIFTA(MD) (tésamoréline pour injection) en fiole unique
04/07/2018
MONTRÉAL, 04 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) a annoncé aujourd’hui qu’elle a déposé un supplemental new drug application (sNDA) auprès de la Food and Drug [...]

Pages